{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:25:51Z","timestamp":1767961551088,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.031","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T14:08:56Z","timestamp":1258553336000},"page":"7214-7218","source":"Crossref","is-referenced-by-count":23,"title":["Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications"],"prefix":"10.1016","volume":"27","author":[{"given":"M.O.V.","family":"Osinubi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Franka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Niezgoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Nok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.B.","family":"Ogunkoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.031_bib1","unstructured":"World Health Organization. World Survey of Rabies No. 34 for the year 1998. WHO Technical Report Series; 2000."},{"key":"10.1016\/j.vaccine.2009.09.031_bib2","unstructured":"World Health Organisation Technical Report Series 931. WHO Expert Consultation on Rabies, First Report; 2005."},{"key":"10.1016\/j.vaccine.2009.09.031_bib3","first-page":"41","article-title":"Rabies in Nigeria: a historical review","volume":"6","author":"Umoh","year":"1979","journal-title":"Int J Zoonoses"},{"key":"10.1016\/j.vaccine.2009.09.031_bib4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0035-9203(81)90436-3","article-title":"Hospital records of human rabies and antirabies prophylaxis in Nigeria 1969\u20131978","volume":"95","author":"Fagbami","year":"1981","journal-title":"Trans R Soc Trop Med Hygiene"},{"key":"10.1016\/j.vaccine.2009.09.031_bib5","unstructured":"Okoh AEJ. Dog ecology with reference to surveillance for rabies and characterization of rabies virus isolates in Plateau State, Nigeria. PhD thesis. Zaria, Nigeria: Ahmadu Bello University; 1986."},{"key":"10.1016\/j.vaccine.2009.09.031_bib6","first-page":"118","article-title":"Canine rabies in Nigeria, 1970\u20131980: reported cases in vaccinated dogs","volume":"9","author":"Okoh","year":"1982","journal-title":"Int J Zoonoses"},{"key":"10.1016\/j.vaccine.2009.09.031_bib7","first-page":"179","article-title":"Evaluation of the immunogenicity of Flury LEP strain rabies vaccine purchased from local vendors","volume":"12","author":"Nottidge","year":"1994","journal-title":"Trop Vet"},{"key":"10.1016\/j.vaccine.2009.09.031_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4314\/tv.v21i2.4475","article-title":"Serological evaluation of the response of Nigerian dogs to Flury LEP vaccine","volume":"21","author":"Ogunkoya","year":"2003","journal-title":"Trop Vet"},{"key":"10.1016\/j.vaccine.2009.09.031_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0264-410X(88)90008-4","article-title":"Vaccination challenge studies with variants of street rabies virus isolated in Nigeria","volume":"6","author":"Okoh","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib10","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2005.09.016","article-title":"Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions","volume":"24","author":"Bahloul","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00262-009-0659-x","article-title":"Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administrated with soluble GM-CSF","volume":"58","author":"Lewis","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.vaccine.2009.09.031_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2009.01.137","article-title":"Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccine expressing consensus JEV and WNV E DIII","author":"Ramanathan","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib13","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1038\/mt.2008.196","article-title":"Phase I\/II study on GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma","volume":"16","author":"Perales","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2009.09.031_bib14","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1128\/JVI.77.16.8729-8735.2003","article-title":"Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines","volume":"77","author":"Barouch","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(96)00281-2","article-title":"Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection","volume":"15","author":"Ray","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects nonhuman primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2009.09.031_bib17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib18","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(00)00475-8","article-title":"Post-exposure DNA vaccination protects mice against rabies virus","volume":"19","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib19","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0264-410X(02)00143-3","article-title":"Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers","volume":"20","author":"Lodmell","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib20","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/S0264-410X(03)00297-4","article-title":"Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody","volume":"21","author":"Lodmell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib21","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0264-410X(03)00504-8","article-title":"Rabies DNA vaccine in the horse: strategies to improve serological responses","volume":"21","author":"Fischer","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib22","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.vaccine.2004.10.018","article-title":"Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats","volume":"23","author":"Cupillard","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1051\/vetres:2007054","article-title":"Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus","volume":"39","author":"Tesoro-Cruz","year":"2008","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2009.09.031_bib24","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1016\/j.vaccine.2008.09.055","article-title":"A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge","volume":"26","author":"Saxena","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib25","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1016\/j.vaccine.2008.09.083","article-title":"Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally","volume":"26","author":"Tesoro Cruz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein II: biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect Immunol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.031_bib28","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/S0264-410X(01)00064-0","article-title":"Genetic engineering of live rabies vaccines","volume":"19","author":"Morimoto","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib30","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1128\/JVI.71.10.7372-7380.1997","article-title":"Rabies virus infects mouse and human lymphocytes and induces apoptosis","volume":"71","author":"Thoulouze","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","article-title":"Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice","volume":"172","author":"Tuffereau","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.031_bib32","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1128\/JVI.65.9.4853-4859.1991","article-title":"Reversible conformational changes and fusion activity of rabies virus glycoprotein","volume":"65","author":"Gaudin","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib33","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus","volume":"17","author":"Osorio","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib34","first-page":"207","article-title":"Development of rabies DNA vaccine using a recombinant plasmid","volume":"49","author":"Rai","year":"2005","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2007.07.018","article-title":"Glycoprotein gene relocation in rabies virus","volume":"131","author":"Wu","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2009.09.031_bib36","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1128\/JVI.76.9.4153-4161.2002","article-title":"Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated","volume":"76","author":"Wu","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib37","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2009.09.031_bib38","first-page":"461","article-title":"Immunogenicity of the ERA G 333 rabies virus strain in foxes and raccoon dogs","volume":"131","author":"Bankovskiy","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2009.09.031_bib39","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1128\/JVI.73.1.510-518.1999","article-title":"Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures","volume":"73","author":"Morimoto","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1994.1105","article-title":"Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against immunity against rabies virus","volume":"199","author":"Xiang","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.031_bib41","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0264-410X(94)90081-7","article-title":"Protective immunity by intramuscular injection of low-doses of influenza-virus DNA vaccines","volume":"12","author":"Ulmer","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune responses to nucleic acid vaccines to rabies virus","volume":"209","author":"Xiang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2009.09.031_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","article-title":"DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses","volume":"16","author":"Bahloul","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2005.08.003","article-title":"One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus","volume":"24","author":"Lodmell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib45","first-page":"8809","article-title":"Altered peptide ligand vaccination with F1t3 ligand expanded dendritic cells for tumor immunotherapy","volume":"98","author":"Forg","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.031_bib46","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.gt.3301783","article-title":"Generation of potent and specific cellular immune responses via in vivo stimulation of dendritic cells by pNGVL3-hFLex plasmid DNA and immunogenic peptides","volume":"9","author":"Forg","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2009.09.031_bib47","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2005.06.027","article-title":"Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis","volume":"23","author":"M\u00e9gret","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.031_bib48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/13550280500385310","article-title":"Glycoprotein-mediated induction of apoptosis limits the spread of attenuated rabies viruses in the central nervous system of mice","volume":"11","author":"Sarmento","year":"2005","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2009.09.031_bib49","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00401-005-0006-z","article-title":"Comparative pathogenesis of recombinant rabies vaccine strain SAD-L16 and SAD-D29 with replacement of Arg333 in the glycoprotein after peripheral inoculation of neonatal mice: less neurovirulent strain is a stronger inducer of neuronal apoptosis","volume":"111","author":"Jackson","year":"2006","journal-title":"Neuropathologica"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T15:59:00Z","timestamp":1685203140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":49,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013553"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}